Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass. 1995

M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
Department of Laboratory Medicine/Blood Coagulation Research, Karolinska Hospital, Stockholm, Sweden.

In 1,800 patients undergoing cardiac surgery over a 2-year period, 11 incidents of abnormal inlet pressure elevations occurred before the membrane oxygenators. In 3 patients, the oxygenators had to be changed during cardiopulmonary bypass. This complication was found to be caused by fibrin formation possibly secondary to precipitation of fibrinogen with other coagulation factors in the heat exchangers of the oxygenators during the cooling phase. Large amounts of fibrin were demonstrated in the heat exchanger of the oxygenators. After careful washing of the apparatus, plasmin was added and fibrin was detected by measuring D-dimer levels. In heat exchangers from uneventful operations, only trace amounts of fibrin were found. Because there were no cold agglutinins demonstrated in the patients before surgery, cryoprecipitation studies were performed soon after surgery. When the patients' plasma samples were studied at different temperatures, from 37 degrees C down to 3 degrees C, cryoprecipitates or a gel (in 1 patient only) were formed. This indicated that there might be something abnormal with regard to fibrinogen-fibrin formation. The study patients were therefore investigated after the acute phase of the operation had ended for various coagulation factors, as well as for fibrin gel network characteristics. The results were compared with those of a control group (n = 10) with uneventful operations. There were no differences between the groups with regard to levels of coagulation factors VII and VIII and von Willebrand factor, although they were increased in both groups. The mean levels of coagulation inhibitors, antithrombin and Protein S, were slightly lower in the study patients. All of these patients had a highly pathologic, ie, tight fibrin gel network, except for the patient in whose sample a gel formed, despite being treated with aspirin or oral anticoagulants. The network was also tighter in some of the controls (v middle-aged reference individuals), although it was significantly tighter in the patients. It is concluded that some individuals who have an increased tendency to form tighter fibrin gel networks might be at increased risk for a severe complication during cardiac surgery performed under hypothermia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010107 Oxygenators, Membrane Devices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. (Dorland, 28th ed) Membrane Oxygenator,Membrane Oxygenators,Oxygenator, Membrane
D011232 Chemical Precipitation The formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution. Precipitation, Chemical
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I

Related Publications

M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
February 1986, The Journal of thoracic and cardiovascular surgery,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
May 1992, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
January 1989, ASAIO transactions,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
January 2004, Neurological research,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
October 1993, The Annals of thoracic surgery,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
January 1979, The Journal of cardiovascular surgery,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
July 2002, Anesthesiology,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
February 1996, The Journal of cardiovascular surgery,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
July 1982, The Journal of thoracic and cardiovascular surgery,
M Blombäck, and P Kronlund, and B Aberg, and K Fatah, and L O Hansson, and N Egberg, and E Moor, and K Carlsson
December 1992, Journal of cardiothoracic and vascular anesthesia,
Copied contents to your clipboard!